Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

Clinical trial NCT00003816 · COMPLETED

Trial details

NCT number: NCT00003816
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Lymphoma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Nonmalignant Neoplasm Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 1998-10-19
Primary completion: 2019-07-12
Enrollment: 361

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.